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Peri-cellular remodeling of mesenchymal extracellular matrices is considered a prerequisite for cell proliferation, motility and development.
Here we demonstrate that membrane-type 3 MMP, MT3-MMP, is expressed in mesenchymal tissues of the skeleton and in peri-skeletal soft
connective tissue. Consistent with this localization, MT3-MMP-deficient mice display growth inhibition tied to a decreased viability of
mesenchymal cells in skeletal tissues. We document that MT3-MMP works as a major collagenolytic enzyme, enabling cartilage and bone cells to
cleave high-density fibrillar collagen and modulate their resident matrix to make it permissive for proliferation and migration. Collectively, these
data uncover a novel extracellular matrix remodeling mechanism required for proper function of mesenchymal cells. The physiological
significance of MT3-MMP is highlighted in mice double deficient for MT1-MMP and MT3-MMP. Double deficiency transcends the combined
effects of the individual single deficiencies and leads to severe embryonic defects in palatogenesis and bone formation incompatible with life.
These defects are directly tied to loss of indispensable collagenolytic activities required in collagen-rich mesenchymal tissues for extracellular
matrix remodeling and cell proliferation during embryogenesis.
Published by Elsevier Inc.Keywords: MT3-MMP; MT1-MMP; Collagenase; Bone formation; Palatogenesis; Cartilage dissolutionIntroduction
The collagens are the most abundant components of the
extracellular matrix. Present in fibrillar, sheet and mesh-like
structures, they constitute the backbone of the diverse
extracellular matrices found in tissues of higher animals
(Ricard-Blum and Ruggiero, 2005). While essential to extra-
cellular matrix function, the fibrillar collagens are by virtue of
their unique molecular properties and mechanical strength also
considered to be major physical barriers blocking motility and⁎ Corresponding author. Fax: +1 301 594 1253.
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doi:10.1016/j.ydbio.2007.10.017proliferation of resident cells (Even-Ram and Yamada, 2005;
Kuivaniemi et al., 1997; Myllyharju and Kivirikko, 2004;
Ushiki, 2002). Most cell types are therefore endowed with
efficient enzymatic tools to modulate and degrade peri-cellular
collagen matrices, as needed, for unimpeded motility and
proliferation during development and homeostasis (Stamenko-
vic, 2003). Since a major proportion of the fibrillar collagen
matrix in bones, teeth and calcified cartilage is amalgamated
with biomineral into “hard collagen”, degradation of collagen-
rich matrices employs two strategies dictated by whether they
are hard or soft. Hard collagen is resorbed by osteoclasts, highly
specialized multinuclear cells of the monocyte–macrophage
lineage, as they acidify the resorption lacuna between their
ruffled border and the mineralized matrix surface and express the
potent lysosomal collagen-cleaving enzyme, cathepsin K (Gelb
et al., 1996; Goto et al., 2003; Saftig et al., 1998; Teitelbaum,
2000; Vaananen et al., 2000). Despite the absence of mineral,
soft fibrillar collagen is an equally tough substrate. Due to its
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breakdown by all but a few select enzymes, working either
through receptor-mediated phagocytosis or peri-cellular proteo-
lysis (Engelholm et al., 2003; Everts et al., 1996; Song et al.,
2006). Peri-cellular collagenolysis is intimately associated with
the true collagenases, so designated not because they are the only
collagen-cleaving enzymes, but rather for their ability to cleave
the collagen triple helix into characteristic 3/4–1/4 breakdown
products at neutral pH and physiological temperature as initially
observed in the tadpole tail (Gross and Lapiere, 1962; Gross and
Nagai, 1965). The true collagenases belong to the matrix metal-
loproteinases (MMPs), a subgroup of secreted and membrane-
bound or membrane-associated zinc-dependent metalloendo-
peptidases numbering more than 25 structurally related enzymes
with highly variable substrate specificities (Brinckerhoff and
Matrisian, 2002; Egeblad and Werb, 2002; Nagase et al., 2006).
Of these, membrane-type 1 matrix metalloproteinase (MT1-
MMP) functions as a potent peri-cellular collagenase capable of
degrading not only soft type I and type II collagen, but also
components of the basement membrane such as laminin and type
IV collagen (Hotary et al., 2003, 2006; Kadono et al., 1998;
Kang et al., 2000; Ohuchi et al., 1997; Sato et al., 1994). MT1-
MMP-deficient mice display severe pleiotropic complications
arising from the inability to degrade soft type I and type II
collagen in mesenchymal tissues (Holmbeck et al., 1999; Zhou
et al., 2000). Despite these physical impediments, MT1-MMP-
deficient mice survive for a considerable time, suggesting that
extracellular matrix breakdown is partially dispensable in early
life, achieved by other means such as receptor-mediated
phagocytosis, or compensated for by protease-independent
strategies for cell motility (Engelholm et al., 2003; Everts et
al., 1996; Friedl, 2004). Finally, the deficit in proteolytic
capacity may be offset, at least partially, through the activity of
other related enzymes. The most obvious candidates to fill this
role are the nearest molecular relatives of MT1-MMP in the
membrane-bound MMP subgroup. Among these, membrane-
type 3 matrix metalloproteinase (MT3-MMP) is closely related
to MT1-MMP in molecular structure as well as in expression
pattern in dynamically remodeling tissues (Szabova et al., 2005;
Takino et al., 1995). We therefore explored the broader function
of MT3-MMP in vivo by generating MT3-MMP-deficient mice
and subsequently crossing them with MT1-MMP-deficient
mice. Here we demonstrate that MT3-MMP is a significant
collagenolytic enzyme in vivo which ameliorates the loss of
MT1-MMP. Accordingly, MT1-MMP/MT3-MMP double-defi-
cient mice are born with severe developmental defects in
collagen-rich tissues, including a severe dysfunction in palatal
shelf formation leading to cleft palate. The physiological
consequence of double deficiency for MT1-MMP and MT3-
MMP is uniform demise of mice shortly after birth caused by
morphogenetic defects, which demonstrate for the first time that
collagen metabolism in utero is a prerequisite for proper
embryonic development. Moreover, these results prove that
peri-cellular collagen degradation is governed by at least two
cooperating molecules of the membrane-type MMP family,
which enable a mechanism in mesenchymal cells required for
remodeling of mesenchymal extracellular matrices in the mouse.Materials and methods
Generation of mice
Laboratory animal experiments in this study were covered under NIDCR
approved animal study proposals.
MT3-MMP (Genbank accession # AC_000026) was disrupted by deleting
sequences between the XbaI site at −728 and the BglII site at +659 bp relative to
the initiation methionine codon. This removes the proximal promoter, exon 1
and part of intron 1 (Fig. 2A). To generate the long arm of the targeting vector
construct a 5.5-kb HindIII subclone was restricted with XbaI, blunted with
Klenow polymerase and restricted with HindIII. The resulting 4.6-kb fragment
was ligated into pKO 924 (Stratagene, La Jolla, CA) blunt ended at the BamH
site and cut with HindIII. A 0.8-kb short arm was isolated from a 1.6-kb HindIII
subclone with PvuII and BglII and ligated into pKO 924 cut with HpaI and
BglII.
The targeting vector was electroporated into W4129S6 ES cells (Taconic,
Hudson, NY) at 800 V/cm, 200 μF using a 0.4-cm cuvette. G418 resistant clones
were screened for the targeted MT3-MMP locus by PCR with primers NeoU1 5′
CCA CTC CCA CTG TCC TTT3′, mt3D1 5′GAC TTA CTATGC CTC ACC
C3′. Agouti offspring were screened by Southern blot on HindIII digested DNA
using a [α-32P]dCTP radio-labeled 0.6-kb intron 1 specific SpeI/HindIII probe
and by PCR using the primers mt3NeoU3 5′CGA CCA CCA AGC GAA
ACA3′ and mt3D3 5′GCT CCC AAA GGC ACC ACA3′. The endogenous
allele was detected with primers mt3wtU2 5′TGATGG ATG CCT GGA GAC3′
and mt3wtD2 5′TGC CCA CTG CTG TTG CTA T3′. Genotyping of MT1-
MMP deficient mice was done with the primers KH17 5′ACA GAG AAC TTC
GTG TTG CCT GAT GAC3′ and 3′16518 5′AGT AGT CGG CGT GGG
TGT3′ for the endogenous allele. The targeted allele was detected with the
primers KH20 5′GTG CGA GGC CAG AGG CCA CTT GTG TAG CG3′ and
Int5 5′AGATGG AGG AGC AGG AAT GG3′.
Expression of MT3-MMP was assessed by RT-PCR on RNA generated from
total neonate tissues. MT3-MMP cDNA was amplified following first strand
synthesis with Superscript (Invitrogen, Gaithersburg, MD) with primers
MT3ex2 5′AAA TAC GGC TAC CTT CCA CCG ACT GAC CCC3′,
Mt3cDNAU4 5′ACC TTC CAC CGA CTG ACC C3′, MT3ex3 5′TCG ATG
CGG TGT ACC AGA CCA GAC AAG AGG C3′, MT3ex4 5′ATG CTT ATT
TCC CTG GAC CCG GAATTG GAG GC3′, MT3ex5 5′CCC ACC GCTATC
ATG GCC CCA TTT TAT CAG TAC A3′, Mt3cDNAD4 5′TGC CAC AAG
CCT GCT CCT A3′ (Genbank accession # NM_019724). For control of RNA
quality, MT1-MMP-specific cDNA was amplified with the primers KH17 5′
ACA GAG ACC TTC GTG TTG CCT GAT GAC3′ and KH 19 5′GAA GAA
GTA GGT CTT CCC ATT GGG CAT3′ (Genbank accession # X83536).
Double deficient MT1-MMP/MT3-MMP mice were generated by crossing
the MT3-MMP-deficient mice to a mouse strain deficient for MT1-MMP
(Holmbeck et al., 1999).
Whole-mount stain of skeletons
Samples were skinned and fixed in 95% EtOH for 24–48 h, eviscerated and
incubated in acetone for 24 h, rinsed in water and stained for 96 h in 0.005%
alcian blue, 0.015% alizarin red, 5% acetic acid, 70% EtOH. Specimens were
cleared in 1% KOH and transferred through graded glycerol solutions and stored
in 60% glycerol.
X-ray analysis of mice
Specimens were imaged in a Faxitron MX-20 (Faxitron Corp., Wheeling,
IL) with Kodak PPL film (Kodak, Rochester, NY) and exposure for 35 s at
30 kEV.
Histomorphometric analysis
Bone measurements in adult mice were made on X-ray images using NIH
image J. Bone length was defined as the longest distance in a straight line from
condyle to condyle. Crania were measured on lateral X-ray images as a straight
line from the middle of the occipital bone to the tip of the nasal bone.
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between the ends of the cortex on the inner lateral aspect of bones positioned
identically was measured.
Recombinant expression of MT3-MMP
The MT3-MMP cDNA was cloned into pWPI (Tronolab). Poly-L-lysine-
coated dishes were seeded with 2.5×106 293t cells in DMEM, 10% FBS and
transfected with pWPI, pSPAX and pVSVG using Lipofectamine Plus
(Invitrogen, Gaithersburg, MD). Cells were infected with 0.5 volume of medium
from transfected 293t cells and 0.5 volume of fresh medium with 8 μg/ml
polybrene.
Cos-7 cells were transfected with mouse MT3-MMP cDNA cloned into
pCMVβ (Clontech, Palo Alto, CA) or with empty pCMVβ as a control.
The DNA was complexed with GeneJuice (EMD Biosciences, Madison,
WI) and the transfection carried out according to the manufacturer's
recommendation's.
Collagen breakdown assay
In vitro collagenolytic activity was assessed by plating 5×104 cells in 25 μl
of DMEM, 10% FBS in the center of a thin film collagen-coated dish. Cos-7
cells were plated at 2.5×104 cells per well. Briefly, the collagen film was
prepared by neutralization and gelling of acid extracted rat tail tendon collagen
(kindly provided by Dr. Jack Windsor). The gel was dried and washed in sterile
water as described (Havemose-Poulsen et al., 1998). Attached cells were
washed and grown in DMEM, 10−9 M IL1β and 10−8 M TNFα (Peprotech,
Rocky Hill, NJ). Collagenolytic activity was visualized by removing the cells
with 0.05% trypsin/EDTA, 1% Triton X-100 and by staining of the collagen
with Coomassie blue. Type II collagen films were prepared by sequential
coating of wells with 3 mg/ml neutralized acid extracted type II collagen (US
Biological, Swampscott, MA). The gels were dried, washed and cells were
plated as described above.
Histology
Tissue was fixed in 4% formaldehyde/PBS, decalcified in 0.25 M EDTA/
PBS, processed and embedded in paraffin, sectioned at 6 μm and stained with
hematoxylin/eosin or used as described in the following sections.
In vivo labeling
Mice were injected IP with 200 mg/kg bromodeoxyuridine (BrdU)
(Sigma, St. Louis, MO) in 0.9% w/v sterile saline 1 h prior to euthanasia.
Cell proliferation was assessed by reacting sections with a BrdU detection
kit (Zymed, South San Francisco, CA) followed by enumeration with NIH
Image J.
Detection of apoptotic cells
Apoptotic cells were detected with the Apoptag kit (Chemicon International,
Temecula, CA) according to the manufacturers' specifications and enumerated
with NIH Image J.
Statistical analysis
Data in Figs. 4B, D, E and Fig. 5I were analyzed by ANOVA one-way test of
variance and Tukey's multiple comparison test. Results are given as the mean
value±SEM. Data in Figs. 4F and G were analyzed by two-tailed Student's T-
test and results are given as mean value±SEM.
In situ hybridization
Sections were hybridized to [α-33P]UTP radiolabeled antisense and sense
probes specific for MT1-MMP and MT3-MMP as previously described
(Szabova et al., 2005).Real-time PCR analysis
cDNA was amplified with a MyIQ thermocycler and IQ5 software (Bio-
Rad, Hercules, CA) initially at 95 °C for 3 min then by 40 cycles of 95 °C for
10 s and 62 °C for 30 s. Melting curves were established by 80 cycles of
heating from 55 °C to 95 °C for 10 s. Each sample was analyzed in triplicate
twice with threshold levels set automatically. Ct values were normalized to the
Ct values for 29S ribosomal protein mRNA. Values were calculated by
subtraction of the control expression level from that of the mutant±SEM and
analyzed by two factor T-test. Primers: MT3-MMP forward: 5′TGATGG ACC
AAC AGA CCG AGA TAA AGA AGG3′, MT3-MMP reverse: 5′GGC CAA
GAT GCA GGG AAT GAC AATAGC3′ (Genbank accession # NM_019724);
29S forward 5′GGA GTC ACC CAC GGA AGT TCG3′, 29S reverse 5′GGA
AGC AGC TGG CGG CAC ATG3′ (Genbank accession # BC024393); MT1-
MMP forward 5′CCC TCC CTC CAG CCT CCC TTC TC3′, MT1-MMP
reverse 5′GAC CGT CTT CTG CTC AGC CCT CAA G3′ (Genbank accession
# X83536).
Generation of MT1-MMP-deficient mammary epithelial cells
Mammary glands from 4- to 7-week-old MT1-MMP-deficient and wild-
type mice carrying the PymT transgene were explanted in DMEM/F12
(Gibco, Grand Island, NY), 5% FBS, glutamine, penicillin, streptomycin,
gentamycin and amphotericin B. Epithelial cells were separated from stromal
fibroblasts by brief trypsinization. The procedure was repeated on successive
passages of the culture until a pure epithelial population of cells was
obtained.
Results
MT3-MMP is co-expressed with MT1-MMP in remodeling
tissue
To test the hypothesis that the viability of MT1-MMP-
deficient mice, hereafter referred to as “(1 ko)” mice, is due to
collagen remodeling by another MT-MMP, we analyzed
global mt3-mmp expression levels by real-time PCR in
collagen-rich tissues of (1 ko) and control wild-type mice.
In addition, we established the local mt3-mmp pattern of
expression by in situ hybridization in (1 ko) mice as well as
the mt1-mmp and mt3-mmp expression patterns in control
littermates. The mt3-mmp messenger RNA level measured in
hind limbs of (1 ko) mice was reduced by 20±9% compared
to wild-type control when analyzed by real-time PCR (N=4),
p=0.04. On the local level, in situ hybridization specific for
both mt3-mmp and mt1-mmp demonstrated a substantially
overlapping pattern of expression when wild-type mouse
femora were analyzed (Figs. 1A, D). Specifically, connective
tissue cells lining the bone surfaces of the primary spongiosa
in the long bones (Fig. 1A, small arrow) and surfaces of the
cortical periosteum (Fig. 1A, arrowheads) displayed expres-
sion of both MT1-MMP and MT3-MMP (Figs. 1A, D). Co-
expression was also found in the groove of Ranvier (Fig.
1A, large arrow) and, in resting and proliferating chondro-
cytes albeit with MT3-MMP more abundantly expressed here
than MT1-MMP (Figs. 1A, D, asterisks). No appreciable
expression was detected in the zone adjacent to the
prospective epiphyseal growth plate where hypertrophic
chondrocytes reside (Fig. 1A, “HC”), but the region
immediately adjacent hypertrophic chondrocytes displayed
intense staining for both mRNAs.
Fig. 1. Expression of MT1-MMP and MT3-MMP in connective tissue, cartilage and bone. Visualization of MT1-MMP and MT3-MMP mRNA expression in the
femur and surrounding connective tissue of neonate mice by in situ hybridization on serial sections. (A) MT1-MMP antisense probe hybridized to (1 wt; 3 wt) tissue
from neonate mouse. Soft connective tissue (arrowheads) and bone lining surfaces (arrow) display signals for MT1-MMP mRNAwith more moderate labeling of the
chondrocytes (asterisk). Expression is localized to the groove of Ranvier (large arrow). Hypertrophic chondrocytes (HC) display little staining. (D) MT3-MMP
antisense probe localizes to similar areas. Chondrocytes of the condyle display more intense staining than in panel A (asterisk). (G) In the absence of MT1-MMP the
distribution of MT3-MMP mRNA is identical to the wild-type expression pattern, compare with panel D. (J) A similar distribution of mRNA is seen for MT1-MMP in
the absence of MT3-MMP. (B, K) MT1-MMP sense control hybridizations. (E, H) MT3-MMP sense control hybridizations. (C, F, I and L) Serial sections stained with
H&E. Scale bar, C=100 μm.
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expression pattern of mt3-mmp (Fig. 1G) there was no
apparent change in the distribution of mRNA comparedto wild type (Fig. 1D) that reflected the recorded
reduction in global expression established by real-time
PCR.
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Based on the results of in situ hybridization we hypothesized
that MT3-MMP played a significant role in mesenchymal cell
function. To test this in vivo, we generated mice with a targeted
null mutation of the mt3-mmp gene (Figs. 2A–B). This
mutation effectively ablated the expression of mt3-mmp as no
messenger RNA from the gene could be detected by a highly
sensitive RT-PCR assay (Fig. 2C). Mice homozygous for theFig. 2. Targeting of the mouse mt3-mmp gene. (A) Strategy for targeting of th
phosphoglycerate kinase promoter-driven neomycin resistance gene, PGK-Neo, solid
HSV-tk, enabling negative selection against random integration of the targeting vector
cleavage sites indicated. Solid black box is exon 1. T.A.: targeted allele, showing exon
the targeting event indicated by panels A and B. Below is the probe used for Southern
(B) Southern blot analysis of DNA obtained from tail biopsies from heterozygous (+/
detection of MT3-MMPmRNA in total tissue from wild-type mouse, lanes 1–5 corre
5–10, respectively. Lane 6: negative control. Lane 7: molecular weight marker. Lane
detectable mRNA for any of the primer combinations used for wild type. Lower pane
negative control. Lane 7: molecular weight marker. Lanes 8–12: detection of 488-bmt3-mmp null mutation, hereafter referred to as “3 ko”, were
born in expected Mendelian ratios, were fertile, but displayed
retarded growth of the skeleton when compared with either their
wild-type (3 wt) or heterozygous (3 +/−) littermates. When
global expression of mt1-mmp was compared between wild-
type mice and 3 ko littermates by real-time PCR, a 37±15%
reduction was measured in the 3 ko mice (N=3), p=0.004.
However, the mt1-mmp message distribution in the absence of
mt3-mmp was unchanged (Fig. 1J) when compared to controle mouse mt3-mmp gene. T.V.: replacement-type targeting vector using the
grey box. The light grey box is the herpes simplex virus thymidine kinase gene,
. E.A.: endogenous allele of MT3-MMPwith significant restriction endonuclease
1 replaced by the PGK-Neo gene. Oligonucleotide primers used for screening of
blot and the restriction fragments detected by the probe followingHindIII digest.
−), homozygous mutant (ko) and wild-type (wt) mice. (C) Upper panel: RT-PCR
spond to DNA complementary to exons 2–10, 2–10, second set, 3–10, 4–10 and
s 8–12: detection of MT3-MMP mRNA from (3 ko) tissue, note the absence of
l: lanes 1–5 detection of MT1-MMP-specific mRNA in wild-type tissue. Lane 6
p MT1-MMP-specific mRNA in (3 ko) tissue.
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expression pattern in (1 ko) mice (Fig. 1G), these data suggested
that the loss of either MT1-MMP or MT3-MMP did not affect
the local expression pattern of the other MT-MMP.
MT1-MMP/MT3-MMP double deficiency leads to perinatal
lethality
Given the apparent overlap of MT1-MMP and MT3-MMP
we sought to characterize the combined function of these two
molecules by the generation of mice doubly deficient for
MT1-MMP and MT3-MMP (1 ko; 3 ko). From crosses
between (1 +/−; 3 +/−) female and (1 +/−; 3 ko) male mice,
offspring of the expected genotype combinations were found at
weaning with the exception of (1 ko; 3 ko) and (1 ko; 3 +/−)
pups. Monitoring of the litters immediately after birth revealed
that a subset of the pups were small, moribund and failed to eat
(Fig. 3A). When genotyped, they consistently were (1 ko; 3 ko)
mice. Survival recorded from the time of birth revealed that
(1 ko; 3 ko) offspring were lower in number than expected and
with just one exception, perished within the first day after birth
while their (1 ko; 3 +/−) littermates had a median survival of 16
days (Fig. 3D). At weaning, however, all pups with the (1 ko;
3 +/−) genotype had died and only pups of (1 wt; 3 +/−), (1 wt;
3 ko), (1 +/−; 3 +/−) and (1 +/−; 3 ko) genotypes had survived.
In contrast, data previously compiled for (1 ko; 3 wt) mice
established a 33% demise prior to weaning (Holmbeck et al.,
1999) and a subsequent median survival of 60 days for weaned
animals. Loss of just one mt3-mmp allele thus significantly
reduces life span in the absence of MT1-MMP. Furthermore,
(1+/−; 3 ko) pups also displayed an increased mortality in the
early days after birth and only 80% of these mice survived
until weaning (Fig. 3D). Together these results demonstrated
that loss of only one mt3-mmp allele in the absence of MT1-
MMP led to premature death before weaning while combined
loss of both genes caused death immediately after birth. In
addition to the mortality of the (1 ko; 3 ko) pups, their numbers
were smaller than expected. To ascertain if the decreased
number of (1 ko; 3 ko) mice was due to intrauterine loss of
embryos, several litters were collected at day E 18.5. At that
stage of gestation, however, the expected ratio of 12.5% (1 ko;
3 ko) mice was recorded thus establishing that the loss of mice
occurred immediately following birth.
Combined MT1-MMP/MT3-MMP deficiency disrupts skeletal
development
Analyses of the (1 ko; 3 ko) pups revealed a severe
craniofacial dysmorphism over and above that observed in
the MT1-MMP deficient mice (Holmbeck et al., 1999).
Specifically, the mid-face of the mice was substantially
shorter (Fig. 3A) and the skull featured a prominent domed
shape, more pronounced than that observed in MT1-MMP-
deficient mice (Fig. 3A). In addition, 80% of the (1 ko;
3 ko) pups had prominent clefting of the palates (Fig. 3B,
asterisk). The loss of both MT1-MMP and MT3-MMP
further resulted in severe stunting of the extremities making(1 ko; 3 ko) pups readily identifiable based on their small
limbs (Fig. 3A).
To further characterize the effect of MT1-MMP/MT3-MMP
deficiency on skeletal development, we stained skeletons with
alcian blue for cartilage and alizarin red for mineralized bone
matrix. These whole-mount stained skeletons revealed that the
combined loss of mt1-mmp and mt3-mmp alleles diminished
bone formation. In particular, the bone of the cranial vault
appeared increasingly thinner with the incremental loss of
mt1-mmp and mt3-mmp alleles. Both the parietal, frontal and
nasal bones were poorly developed (Fig. 3C, asterisk). Double
deficiency for MT1-MMP and MT3-MMP further affected the
formation of cortical bone, specifically in the humeri and femora
where a dramatic shortening of the bone cortices could be
observed (Figs. 4A, C). This effect, like the effect on skull bones,
was proportional to the number of mt1-mmp and mt3-mmp
alleles lost compared to wild type, with the most severe effect
observed in the (1 ko; 3 ko) genotype. Measurement of the
humoral cortical length at E 18.5 days demonstrated gradual
reduction compared to control of 87±0.7% in (1 +/−; 3 ko) pups
(pb0.01), 83±1.6% in (1 ko; 3 wt) mice (pb0.001), 76±4.82%
in (1 ko; 3 +/−) mice (pb0.001) and 51±4.75% in (1 ko; 3 ko)
mice (pb0.001) (Figs. 4A, B). Despite diminished early growth
compared to wild type, none of the surviving mice displayed a
reduction in humerus length at 20 days of age comparable to
that observed in (1 ko; 3 wt) mice (Supplemental Fig. 1).
However, compared to control mice significant differences were
again observed at 30 days of age, where (1 wt; 3 ko) littermate
humeri lengths were 92±1% (pb0.001), (1 +/−; 3 +/−) humeri
were 94±1.2% (pb0.01) and (1 +/−; 3 ko) humeri 90±0.7%
(Fig. 4E). At 50 days only (1 +/−; 3 +/−) humeri at 93±0.7% of
control length (pb0.05) and (1 +/−; 3 ko) at 87±1% of control
(pb0.001) were significantly shorter than control (bar graph not
shown).
Femora were likewise shortened in length at E 18.5 to
86±2% of control for (1 +/−; 3 ko) mice (pb0.01), 86±1%
for (1 ko; 3 wt) mice (pb0.01), 74±3.3% for (1 ko; 3 +/−)
(pb0.001) and 65±2.5% for (1 ko; 3 ko) mice (pb0.001)
(Figs. 4C, D). In contrast to humeri, femora at 30 days no
longer displayed statistically significant reduction in length
when compared to control samples (data not shown).
Loss of MT1-MMP and MT3-MMP affects the viability of
skeletal cells
The dramatic impairment of long bone formation and cranial
bone formation combined with the expression of MT1-MMP
and MT3-MMP in both cartilage and bone cells suggested that
the reduced availability or outright loss of these two proteolytic
enzymes had affected the viability of osteogenic cells and the
proliferation of chondrocytes. Enumeration of apoptotic bone-
lining cells in femora of newborn mice revealed that loss of
MT1-MMP and MT3-MMP imparted a significantly reduced
viability dependent on the number of mt1-mmp and mt3-mmp
alleles retained (Fig. 4F, Supplemental Fig. 2). Thus, compared
to control (1 +/−; 3 wt) mice the number of apoptotic nuclei in
(1 ko; 3 ko) mice was increased 280±70% (pb0.05).
Fig. 3. Combined MT1-MMP/MT3-MMP deficiency leads to severe developmental defects and perinatal death. (A) E 18.5 embryo double deficient for MT1-MMP
and MT3-MMP (1 ko; 3 ko) is smaller than the (1 wt; 3 +/−) control. Note the profound dome-shaped head and the short nose and stubby limbs. Scale bar=5 mm. (B)
Combined loss of MT1-MMP and MT3-MMP causes incomplete fusion of the palatal shelves and 80% of (1 ko; 3 ko) mice have cleft palate, asterisk in panel B. Scale
bar=1 mm. (C) Whole-mount preparation of skeletons from newborn mice stained with alcian blue for detection of cartilage and alizarin red for detection of
mineralized bone matrix. The successive loss ofmt1-mmp andmt3-mmp alleles lead to diminished bone formation in the skull, reduction in the cranium size, shortened
limbs and reduction in the size of the thorax. Note the virtual absence of the parietal bone in the (1 ko; 3 ko) mice (asterisk). Scale bar=5 mm. (D) Kaplan–Meyer plot
of survival of pups prior to weaning.
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Fig. 4. Combined MT1-MMP/MT3-MMP deficiency leads to embryonic limb deformity, growth retardation and cell demise. (A) Whole-mount preparations of upper
extremities from newborn mouse pups stained with alcian blue for cartilage and alizarin red for mineralized bone. The successive loss of mt1-mmp and mt3-mmp
alleles leads to shortening of the long bones in the arm. The formation of the cortical bone is particularly affected and leads to a deformity of the humerus. Scale
bar=5 mm. (B) Length of the humeral cortices in E 18.5 embryos. (C) Whole-mount preparation of lower extremities from E 18.5 embryos. Note the severe impact of
combined MT1-MMP/MT3-MMP loss on femoral development. (D) Femoral length at E 18.5. (E) Humeral length at 30 days. (F) Enumeration of apoptotic cells
associated with bone surfaces in the distal femoral epiphysis and primary spongiosa of neonate mice. (G) Enumeration of proliferating chondrocytes in the distal
femoral epiphysis, zone of proliferating chondrocytes. Bar graphs represent the mean value and error bars indicate standard error of the mean.
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femoral epiphysis revealed a gradual reduction in cell divisions
with the successive loss of alleles, culminating in the (1 ko;
3 ko) mice (Fig. 4G) where only of 25.7±4.8% (pb0.0001) of
the cell count found in (1 wt; 3 wt) mice was recorded.
Combined MT1-MMP/MT3-MMP deficiency disrupts both
intramembranous and endochondral ossification processes
The reduction in bone cell viability and chondrocyte
proliferation was consistent with the findings in sections offemora from (1 ko; 3 ko) mice (Figs. 5A–H, Supplemental Fig.
3). Double-deficient mice displayed a markedly elongated zone
of hypertrophic chondrocytes (Fig. 5, compare arrows in E vs.
F). The core of the primary ossification center where hema-
topoietic cells normally reside was occupied by a conspicuous
island of un-degraded hypertrophic cartilage (Fig. 5H, asterisk)
and the zone of proliferating chondrocytes in the epiphysis was
marked by a depletion of cells (Fig. 5F, asterisk). In addition to
short bone cortices, a striking lack of trabecular bone in the
marrow cavity (Fig. 5H) was evident. With the exception of the
short cortices, these observations pointed to a deficit in the
Fig. 5. Combined loss of MT1-MMP and MT3-MMP affects both endochondral and intramembranous ossification. (A–D) Sagittal sections of femora from newborn
mice stained with H&E. (A–H) The successive loss of mt1-mmp and mt3-mmp alleles leads to increasing diminution of longitudinal growth in (1 ko; 3 ko) mice
stemming from inability to properly remodel the calcified cartilage and replace it with bone. Boxed areas in panels A and D are shown in higher power magnification
below in panels E, G and F, H, respectively. Note the elongated zone of hypertrophic cartilage (compare arrow in E to F) and the reduced number of proliferating
chondrocytes (F, asterisk). A conspicuous island of undegraded hypertrophic cartilage remains in the marrow cavity of (1 ko; 3 ko) mice (asterisk, H) and trabecular
bone in the primary spongiosa of the (1 ko; 3 ko) mouse is largely absent (compare G vs. H). (I) Measurements of cranium sizes of mice at 30 days. (J, K) Partial loss of
MT1-MMP or MT3-MMP affects craniofacial development. (J) X-ray image illustrates how the adult (1 wt; 3 +/−) mice can be differentiated from (1 +/−; 3 ko) mice
on the basis of the cranium size and shape at 300 days of age. (K) At 75 days of age the snout of a (1 +/−; 3 ko) mouse is conspicuously shorter compared to that of the
(1 wt: 3 ko) littermate. Bar graph in panel I represents the mean value and error bars indicate standard error of the mean. Scale bar, A–H=100 μm; J, K=5 mm.
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205J. Shi et al. / Developmental Biology 313 (2008) 196–209endochondral ossification process not otherwise seen in single-
deficient (1 ko) or (3 ko) mice and the likely cause for the
shortened and thickened diaphysis (Figs. 5A–C vs. D). In the
femur of the (1 ko; 3 +/−) mice, the extended hypertrophic
chondrocyte zone and a partially reduced amount of trabecular
bone could be observed (Fig. 5B). These defects were, however,
less pronounced than those seen in the (1 ko; 3 ko) mice,
demonstrating the powerful contribution that just one mt3-mmp
allele conferred on connective tissue development.
Defective cranial bone formation and palatogenesis in
MT1-MMP/MT3-MMP-deficient mice
As suggested by the whole-mount skeletal stains, the loss of
MT1-MMP and MT3-MMP significantly affected the growth of
the cranium. Initially analysis of mice surviving weaning
revealed no overt differences in skull size except for that of
(1 ko; 3 wt) mice (Supplemental Fig. 1). However further aging
of the mice demonstrated that growth is dependent on MT3-
MMP. Accordingly, loss of just one mt3-mmp allele signifi-
cantly reduced cranial size at 30 days (Fig. 5I). Mice thus
displayed skull lengths when compared to control mice of 95%
for (1 wt; 3 +/−) mice (pb0.05), 91% for (1 wt; 3 ko)
(pb0.001), 91% for (1 +/−; 3 +/−) and 86% for (1 +/−; 3 ko)
mice (pb0.001). The latter genotype was the most profound in
terms of the quantitative reduction in size, but the growth
reduction in these mice also affected other aspects of
ossification resulting in a unique head shape readily identifiable
by an unbiased observer (Figs. 5J, K). Collectively, these data
demonstrated that formation of long bone and cortical bone (as
well as other intramembranous bones) significantly depended
not only on MT1-MMP but also MT3-MMP.
The most severe effect of the deficit in bone formation was
seen in the mid-cranium of 1 ko; 3 ko embryos and newborn
mice where the formation of the palatine bone was absent (Figs.
6A–F, Supplemental Fig. 4). Upon inspection of serial sections
from E 11.5 to E. 15.5 embryos the cause was established to be
the reduction of palatal shelf growth and disabled fusion (data
not shown). Despite timely elevation of the shelves the lack of
growth prevented fusion of the shelves thereby disrupting the
formation of the secondary palate in which the osteogenic tissue
differentiates. The ensuing ossification of the palatine bone was
abrogated, resulting in clefting in 80% of the (1 ko; 3 ko) mice
(Fig. 6F). Moreover, the ptygoriod bone was underdeveloped
and the maxilla and other mid-cranial bones such as the vomer
(Fig. 6D, asterisk) displayed signs of hypoplasia with pitting
and lack of fusion to the maxilla (Figs. 6C, D).
In the mandible, individual bone trabeculae of the mutant
mice were aberrant and thinner than the control (Figs. 6G, H).
Notably, the number of bone lining cells was substantially
reduced and the majority of connective tissue cells were instead
dispersed between the individual bone trabeculae. Meckel's
cartilage was conspicuous in size suggesting the exacerbation of
an already impaired cartilage remodeling described previously
in MT1-MMP-deficient mice (Holmbeck et al., 2003).
In the cranial vault, the gene deficiency affected intramem-
branous bone formation (Figs. 6I–J). High power magnificationof the parietal bone near the sagittal suture revealed that the
bone of (1 ko; 3 ko) mice was abnormal and contained
azurophilic patches uncommon in normal bone matrix (Fig. 6J,
arrow).
MT3-MMP is a peri-cellular collagenolytic enzyme
The most prominent indication that substrates of MT1-MMP
and MT3-MMP are identical is that mt3-mmp, when expressed
from only one allele, facilitates survival of the mice during most
of the pre-weaning period. To test this notion mechanistically,
we employed a semi-quantitative collagen degradation assay
(Holmbeck et al., 1999). We infected MT1-MMP-deficient
(collagenase insufficient) immortalized mammary epithelial
cells with an mt3-mmp lentiviral expression vector or an empty
vector as negative control. As a positive control, we used
immortalized MT1-MMP-sufficient mammary epithelial cells.
After plating on a high-density fibrillar type I collagen
substratum, MT1-MMP-sufficient cells extensively degraded
the underlying collagen following stimulation of collagen
breakdown (Fig. 7A). MT1-MMP-deficient cells infected with
the empty viral vector predictably failed to degrade the
underlying substratum (Fig. 7B). In contrast to prior observa-
tions (Chun et al., 2004), MT1-MMP-deficient cells infected
with the MT3-MMP expressing virus displayed the most robust
collagenolytic activity in the assay thereby proving that MT3-
MMP alone was sufficient to degrade high-density fibrillar type
I collagen as can MT1-MMP (Fig. 7C). To confirm these results
we employed Cos-7 cells for transfection with an MT3-MMP
expressing vector or empty vector. When plated on type I
collagen matrices as described above these cells likewise
demonstrated ability to degrade collagen when expressing
MT3-MMP (Supplemental Fig. 5).
Given the abundant evidence of defective cartilage remodel-
ing in the (1 ko; 3 ko) mouse (Figs. 5H, K, Fig. 6H), we also
tested if MT3-MMP expressing cells could cleave a type II
collagen matrix. MT1-MMP-sufficient cells indeed proved
capable of degrading the matrix although with less efficiency
than they degraded type I collagen (Fig. 7D). MT1-MMP
deficient cells again proved incapable of degrading the under-
lying type II collagen matrix. However, when MT1-MMP-
deficient cells infected with MT3-MMP expressing virus were
plated on type II collagen, lytic zones in the matrix were
detected (Fig. 7F).
Together these data demonstrate that the loss of MT3-MMP
leads to a deficit in a potent peri-cellular collagenolytic
enzyme, which can partially complement the role of MT1-
MMP in peri-cellular collagen degradation. Combined with the
analysis of MT1-MMP/MT3-MMP double-deficient mice,
these data provide compelling evidence for the function of
MT3-MMP as a major peri-cellular collagenolytic enzyme in
the mouse.
Discussion
Pursuing the hypothesis that MT1-MMP deficiency is abated
by a functionally equivalent enzyme, we document here a
Fig. 6. Combined loss of MT1-MMP and MT3-MMP leads to severe craniofacial developmental defects. (A) Whole-mount (1 wt; 3 wt) cranium stained with alcian
blue for cartilage and alizarin red for mineralized bone at E 17.5 and visualized from the base in the absence of the mandible. (B) (1 ko; 3 ko) Littermate displaying a
prominent absence of palatine bone fusion, asterisk. (C) Cranium of newborn wild-type mouse showing the fused palatine bone (p) and the ptygoroid bone (pt). (D)
The equivalent view of a (1 ko; 3 ko) cranium with overt lack of palatine bone fusion (edges traced by white lines). The unfused palatine bone offers unobstructed view
of the sphenoid (s) and pre-sphenoid (ps) bones and the underdeveloped vomer (asterisk). (E, F) Cross-section through the oral cavity and pharynx of newborn
littermates. In panel F, the failure to develop the palatal shelves leaves the mouse with a clefted palate, asterisk, above the tongue (t). (G, H) The loss of MT1-MMP and
MT3-MMP severely affects the formation of mandibular bone and remodeling of Meckel's cartilage (mc). In panel H, the bone trabeculae are thin and few bone lining
cells are found on their surfaces, arrow, compare with G, arrow. The bone is substituted with areas rich in connective tissue cells (mu, muscle; n, nerve). (I, J) In the
cranial vault, the bone formation is likewise affected and the parietal bone, asterisks, near the sagittal suture is aberrant looking with azurophilic substance in the matrix
(arrow) and irregular surfaces (compare J with I). Scale bars, A, B=2 mm; C, D=0.5 mm; E–H=100 μm; I, J=50 μm.
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Fig. 7. MT3-MMP is a peri-cellular collagenolytic enzyme. (A) Wild-type (MT1-MP sufficient) cells degrade a high-density fibrillar type I collagen layer when plated
on top of this matrix. Following removal of the cells collagenolytic activity is visualized by staining of the matrix with Coomassie blue. Degraded matrix appears as
clear lytic zones in the collagen layer. (B) Cells derived fromMT1-MMP deficient mice infected with the empty pWPI-GW lentiviral vector display complete inability
to degrade collagen. (C) When MT1-MMP-deficient cells are infected with MT3-MMP expressing lentivirus, pWPI MT3, cells regain the ability to cleave fibrillar
collagen thus demonstrating that MT3-MMP is a collagenolytic enzyme. Note the robust removal of the matrix by the cells. (D) Wild-type cells also display ability to
degrade type II collagen when plated on this matrix (arrows). (E) Loss of MT1-MMP disrupts type II collagen degradation. (F) Expression of MT3-MMP in MT1-
MMP-deficient cells restores the ability to degrade type II collagen (arrows).
207J. Shi et al. / Developmental Biology 313 (2008) 196–209mechanistic linkage betweenMT1-MMP and its close molecular
relative, MT3-MMP, by the use of mouse genetics.
While the loss of MT3-MMP in itself does not lead to overt
physiological deficits, we document an impact on bone
formation in the cranium and long bones indicating that MT3-
MMP is not merely functionally redundant but required for
unimpeded remodeling of extracellular matrix (Figs. 5, 6).
Combined with MT1-MMP deficiency, however, it is abun-
dantly clear that loss of either one or two alleles of mt3-mmp is
associated with a significant exacerbation of the impact of MT1-
MMP deficiency in a dosage-dependent manner. The survival of
MT1-MMP-deficient mice, despite severe collagen indigestion,
originally prompted us to consider if fibrillar collagen
metabolism in utero is dispensable for proper development.
We demonstrate here that loss of the combined collagenolytic
activities associated with MT1-MMP and MT3-MMP is
compatible with gestation to term, but with severe develop-
mental defects in appendicular and craniofacial skeleton as
consequences. These deficits which affect alimentation and
locomotion are associated with uniform perinatal lethality and
suggest an absolute requirement for collagen remodeling during
development. Furthermore we document that both alleles of
MT3-MMP are required for viability past weaning in an MT1-
MMP-deficient background.We observe several effects of combined loss of MT1-MMP
and MT3-MMP at the cellular level, which explain the gross
phenotypic characteristics encountered in these animals. These
observations are distinct from other skeletal deficits associated
with the disruption ofMMPs (Inada et al., 2004; Itoh et al., 1997;
Mosig et al., 2007; Stickens et al., 2004). The strong effect on
both bone and cartilage tissues in this model can be traced to the
reduced viability of bone surface-associated cells and the
diminished proliferation of chondrocytes observed in the
prospective epiphyseal growth plate. These deficits are tied to
the loss of two major peri-cellular collagenolytic activities,
which enable cells to negotiate the extracellular matrix and
facilitate functions such as bone apposition and chondrocyte
proliferation. Both these functions are essential for the formation
of long bone — a combined product of cortical intramembra-
nous bone apposition and coordinated elongation of the core
trabecular bone derived by endochondral ossification. In this
process, chondrocytes of the epiphysis in succession undergo
proliferation, programmed hypertrophy, calcification and ulti-
mately resorption, thereby leaving behind cartilage cores on
which bone matrix is deposited (Ortega et al., 2004; Provot and
Schipani, 2005).
The impact of reduced cell proliferation predictably affects
longitudinal growth, however, partial or complete MT3-MMP
208 J. Shi et al. / Developmental Biology 313 (2008) 196–209deficiency in an MT1-MMP-deficient background also affects
resorption of calcified cartilage and leads to a retardation of
endochondral ossification throughout the skeleton.
This observation is not predated by similar findings in mice
with single MT1-MMP deficiency and demonstrates that MT3-
MMP alone can support the functions of cells required for
essential remodeling steps in endochondral ossification and the
ensuing formation of trabecular bone matrix. Because the
principal resorption of calcified cartilage is thought to be
mediated by osteoclasts, our observations do not immediately
fit into the established model of endochondral ossification.
However, not all parts of the hypertrophic cartilage zone are
mineralized; deposition of mineral is confined to the long-
itudinal septae between individual chondrocytes while the
transverse septae maintain an unmineralized state (Sawae et al.,
2003). The transverse septae are therefore not substrates for
fully differentiated osteoclasts but are considered to be degraded
by cells of a vascular endothelial phenotype associated with the
invading vessels (Sawae et al., 2003). MT1-MMP and MT3-
MMP are expressed in endothelial cells and we hypothesize,
based on our demonstration of type II collagen degradation by
both proteinases, that invading vascular cells are capable of
degrading the type II collagen-rich matrix in unmineralized
transverse septae (Plaisier et al., 2004; Sawae et al., 2003). We
have previously described the role of MT1-MMP in degradation
of unmineralized cartilage during vascular canal formation, an
angiogenic process analogous to transverse septum remodeling
(Alvarez et al., 2005; Blumer et al., 2005; Holmbeck et al.,
1999; Lutfi, 1970). With the loss of MT3-MMP yet another
important molecular tool for unmineralized cartilage dissolution
in transverse septae is gone. The access of osteoclasts to the
longitudinal septae thereby is obstructed, which in turn retards
the resorption of the mineralized cartilage matrix and results in
an elongated zone of hypertrophic chondrocytes.
The growth of long bone is not only determined by the rate of
chondrocyte proliferation but is also highly dependent on the
coordinated elongation of the cortical bone. This process is
dependent on both bone apposition and remodeling of the
cortex interface with the condylar cartilage at the groove of
Ranvier (Ranvier 1873; Shapiro et al., 1977). We have
previously demonstrated that timely remodeling of the unmi-
neralized cartilage matrix here is critical for growth of the long
bone and inability to remodel the matrix at this site in effect
clamps the growth of the cortex and disables bone elongation
(Holmbeck et al., 2003). We observe here that exacerbation of
the collagen indigestion in the MT1-MMP/MT3-MMP-defi-
cient mice leads to further reduction in this interface remodeling
function affecting cortical bone growth even in utero.
The effect on bone formation is also evident in the mandible
where bone-lining cells are severely depleted and the bone
trabeculae are thin and separated by highly cellular spaces
suggesting that cells are arrested in their resident matrix. This
phenomenon was previously described in MT1-MMP-deficient
mice where scarring and fibrosis ensues from a defective matrix
remodeling in bone lining soft connective tissue. However, this is
restricted to aged MT1-MMP-deficient mice, whereas a similar
observation can be made in neonate MT1-MMP/MT3-MMP-deficient mice. This important connection between soft tissue
remodeling and impact on the hard mineralized tissue is also the
root cause of defective palatogenesis in MT1-MMP/MT3-MMP-
deficient mice. Palatal shelf formation is a combined process of
cell proliferation, migration, extensive soft connective tissue
remodeling and intramembranous bone formation (Greene and
Kochhar, 1973; Hilliard et al., 2005). The defective palatogenesis
inMT1-MMP/MT3-MMP-deficient mice stems from diminished
growth of the palatal shelves, rather than a defect in their elevation
and fusion. This points to an early defect in cell proliferation akin
to that observed in the cartilage of double-deficient mice. Notably,
the mesenchyme in the prospective palatal shelves is highly
enriched for type III collagen — a substrate of MT3-MMP
(Morris-Wiman and Brinkley, 1992; Shimada et al., 1999). We
hypothesize that the cellular defect in remodeling of the
extracellular matrix there, as elsewhere in collagen-rich tissues,
leads to the reduction of palatal shelf growth. The subsequent
failure to establish the secondary palate eliminates the morpho-
logical structure in which an osteogenic mesenchyme ordinarily
gives rise to the palatine bone.
In conclusion, our data demonstrate that peri-cellular
collagen dissolution in vivo is facilitated through two
independent proteolytic enzymes, which cooperatively degrade
collagen-rich extracellular matrices essential for development
and sustained postnatal viability.
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